Ondansetron vs Upadacitinib
Ondansetron vs Upadacitinib: Overview
This comparison examines the pharmacological differences between Ondansetron and Upadacitinib.
Mechanism of Action
Ondansetron: Selective 5-HT3 receptor antagonist.
Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.
Pharmacokinetics
Half-life: Ondansetron — 3-5 hours; Upadacitinib — 9-14 hours.
Chemical Properties
Molecular Formula: Ondansetron — C18H19N3O; Upadacitinib — C17H19F3N6O.
Molecular Weight: Ondansetron — 293.3660 g/mol; Upadacitinib — 380.3700 g/mol.
Type: Ondansetron — Small molecule; Upadacitinib — Small molecule.